AIMS AND OBJECTIVES: To evaluate the hypolipidemic effect of Acacia modesta (AM) leaves extract in comparison with glibenclamide in alloxan induced diabetic rats. STUDY DESIGN: An Experimental study PLACE AND DURATION: This study was carried out at the Shifa College of Medicine and National Institute of Health, Islamabad from October 2010 to October 2011. MATERIALS AND METHODS: One hundred and twenty healthy male albino rats were equally divided into four groups (n=30), groups A (normal control), B (diabetic control), C (diabetic rats treated with glibenclamide) and group D (diabetics rats treated with AM leaves extract). Diabetes was induced in overnight fasting(14-16 hrs) rats of groups B, C and D by single intraperitoneal injection of alloxan (110 mg/kg b.w) and was confirmed by measuring fasting blood glucose level >200 mg/dl on 4th post-induction day. Rats of group C and D were treated with glibenclamide (900 µg/kg b.w) and Acacia modesta leaves extract (400 mg/kg b.w) respectively for 3 weeks. Serum triglycerides, cholesterol, LDL and serum HDL levels were measured by homogenous enzymatic colorimetric method. RESULTS: Asignificant decrease (p<0.05) in the levels of serum triglyceride, cholesterol and LDL levels, and an increase in HDL levels were noticed in rats treated with glibenclamide (group C) and AM leaves extract (group D) than the diabetic control rats (group B). Group C showed a significant decrease in the levels of cholesterol, triglycerides and LDL with a significant increase in levels of HDL as compared to group D. CONCLUSION: Administration of AM leaves extract results in hypolipidaemic activity in diabetic rats as that of glibenclamide.